MedPath

A clinical trial to study the effect of Gluma and Er,Cr:YSGG Laser in patients with tooth hypersensitivity

Phase 4
Registration Number
CTRI/2024/03/064425
Lead Sponsor
Dr. Sagarika Sortey
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Premolar with Class 3 Non-Carious Cervical Lesion showing hypersensitivity.

Patient showing willingness to participate in the study for 1 month.

Exclusion Criteria

i. Carious lesion on the selected or neighbouring tooth.

ii. Restorations on the selected tooth.

iii. Any desensitizing therapy on the selected tooth during the last 6 months

iv. Periodontal surgery within last 3 months

v. Nonvital tooth, cracked tooth syndrome

vi. Tender tooth in the same quadrant as the hypersensitive teeth.

vii. Patients undergoing orthodontic treatment

viii. Pregnant/lactating females.

ix. Smokers, alcoholics.

x. Patients taking antibiotics/analgesics/anti-inflammatory/anti-depressive drugs, patients having cognitive dysfunctions/general communication difficulties.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)To assess the hypersensitivity in Non-Carious Cervical Lesions (NCCLs). <br/ ><br>2)To assess the effect in hypersensitivity in Non-Carious Cervical Lesions (NCCLs) restored with adhesive resin after pre-treatment with Gluma and Er,Cr:YSGG laser vs without pre-treatment. <br/ ><br>3)To compare the efficacy of Gluma and Er,Cr:YSGG laser in reducing hypersensitivity in Non-Carious Cervical Lesions (NCCLs) restored with adhesive resin vs without pre-treatment. <br/ ><br>Timepoint: VAS scale will be used to measure the pain response before treatment 24hrs post restoration 15 days and 1 month. <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
no secondary outcomeTimepoint: nil
© Copyright 2025. All Rights Reserved by MedPath